First report of the point-of-care TEG: A technical validation study of the TEG-6S system

Platelets

Volumn 27, Issue 7, 2016, Pages 642-649

  Gurbel, Paul A ^a   Bliden, Kevin P ^a   Tantry, Udaya S ^a   Monroe, Amy L ^b   Muresan, Adina A ^d   Brunner, Norman E ^d   Lopez Espina, Carlos G ^e   Delmenico, Peter R ^e   Cohen, Eli ^d   Raviv, Gabriel ^d   Haugen, DeAnna L ^c   Ereth, Mark H ^c  

^a INOVA HEART AND VASCULAR INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c MAYO CLINIC   (United States)

^d Coramed Technologies ^*  (United States)

^e HAEMONETICS CORPORATION   (United States)

Author keywords

Bleeding; hemostasis; platelet function tests; point of care systems; thrombelastography; thrombosis

Indexed keywords

ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; FIBRINOGEN; HEPARIN LYASE; KAOLIN; ANTITHROMBOCYTIC AGENT;

ACCURACY; ADULT; AGED; ANALYZER; ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOTTING TIME; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART MUSCLE REVASCULARIZATION; HEMOSTASIS; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MICROFLUIDICS; POINT OF CARE SYSTEM; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOELASTOGRAPHY; VALIDATION STUDY; VERY ELDERLY; VISCOELASTICITY; BLOOD CLOTTING PARAMETERS; CLINICAL TRIAL; DRUG EFFECTS; HEART SURGERY; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; STANDARDS;

CARDIAC SURGICAL PROCEDURES; FEMALE; HEMOSTASIS; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; PLATELET AGGREGATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; POINT-OF-CARE SYSTEMS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; THROMBELASTOGRAPHY;

EID: 84962851435     PISSN: 09537104     EISSN: 13691635     Source Type: Journal    
DOI: 10.3109/09537104.2016.1153617     Document Type: Article

References (17)

1. H.R.Roberts, D.M.Monroe, M.A.Escobar Current concepts of hemostasis:implications for therapy. Anesthesiology 2004;100:722–730.
2. G.Marechal, M.E.Leroux, M.Samama Thrombodynamography (thromboelastography). Its present place in clinical practice. Presse Med 1960;68:1919–1922.
3. Y.Kang Thromboelastography in liver transplantation. Semin Thromb Hemost 1995;21(Suppl 4):34–44.
4. L.Shore-Lesserson, H.E.Manspeizer, M.DePerio, S.Francis, F.Vela-Cantos, M.A.Ergin Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999;88:312–319.
5. L.T.Da Luz, B.Nascimento, A.K.Shankarakutty, S.Rizoli, N.K.Adhikari Effect of thromboelastography (TEG®) and rotational thromboelastometry (ROTEM®) on diagnosis of coagulopathy, transfusion guidance and mortality in trauma:descriptive systematic review. Crit Care 2014;18:518.
6. M.C.Yeung, S.Y.Tong, P.Y.Tong, B.H.Cheung, J.Y.Ng, G.K.Leung Use of viscoelastichaemostatic assay in emergency and elective surgery. Hong Kong Med J 2015;21:45–51.
7. D.J.McCrath, E.Cerboni, R.J.Frumento, A.L.Hirsh, E.Bennett-Guerrero Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesth Analg 2005;100:1576–1583.PubMed PMID:15920177.
8. P.A.Gurbel, K.P.Bliden, I.A.Navickas, E.Mahla, J.Dichiara, T.A.Suarez, M.J.Antonino, U.S.Tantry, E.Cohen Adenosine diphosphate-induced platelet-fibrin clot strength:a new thromboelastographic indicator of long-term poststenting ischemic events. Am Heart J 2010;160:346–354.
9. P.A.Gurbel, K.P.Bliden, K.Guyer, P.W.Cho, K.A.Zaman, R.P.Kreutz, A.K.Bassi, U.S.Tantry Platelet reactivity in patients and recurrent events post-stenting:results of the PREPARE POST-STENTING Study. J Am Coll Cardiol 2005;46:1820–1826.
10. E.Mahla, T.A.Suarez, K.P.Bliden, P.Rehak, H.Metzler, A.J.Sequeira, P.Cho, J.Sell, J.Fan, M.J.Antonino, U.S.Tantry, P.A.Gurbel Platelet function measurement-based strategy to reduce bleeding and waiting time in clopidogrel-treated patients undergoing coronary artery bypass graft surgery:the timing based on platelet function strategy to reduce clopidogrel-associated bleeding related to CABG (TARGET-CABG) study. Circ Cardiovasc Interv 2012;5:261–269.
11. R.C.Carroll, R.M.Craft, J.J.Chavez, C.C.Snider, R.K.Kirby, E.Cohen Measurement of functional fibrinogen levels using the Thrombelastograph. J Clin Anesth 2008;20:186–190.
12. TEG5000 User Manual. Haemonetics Corp. 2007.
13. Guide to PlateletMapping®. Haemonetics Corp. 2006.
14. U.S.Tantry, L.Bonello, D.Aradi, M.J.Price, Y.H.Jeong, D.J.Angiolillo, G.W.Stone, N.Curzen, T.Geisler, J.Ten Berg, A.Kirtane, J.Siller-Matula, E.Mahla, R.C.Becker, D.L.Bhatt, R.Waksman, S.V.Rao, D.Alexopoulos, R.Marcucci, J.L.Reny, D.Trenk, D.Sibbing, P.A.Gurbel Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding. J Am Coll Cardiol 2013;62:2261–2273.
15. D.Aradi, A.Kirtane, L.Bonello, P.A.Gurbel, U.S.Tantry, K.Huber, M.K.Freynhofer, J.Ten Berg, P.Janssen, D.J.Angiolillo, J.M.Siller-Matula, R.Marcucci, G.Patti, F.Mangiacapra, M.Valgimigli, O.Morel, T.Palmerini, M.J.Price, T.Cuisset, A.Kastrati, G.W.Stone, D.Sibbing Bleeding and stent thrombosis on P2Y12-inhibitors:collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary intervention. Eur Heart J 2015;36:1762–1771.
16. V.A.Ferraris, S.P.Saha, J.H.Oestreich, H.K.Song, T.Rosengart, T.B.Reece, C.D.Mazer, C.R.Bridges, G.J.Despotis, K.Jointer, E.R.Clough; Society of Thoracic Surgeons. 2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations. Ann Thorac Surg 2012;94:1761–1781.
17. S.Windecker, P.Kolh, F.Alfonso, J.P.Collet, J.Cremer, V.Falk, G.Filippatos, C.Hamm, S.J.Head, P.Jüni, A.P.Kappetein, A.Kastrati, J.Knuuti, U.Landmesser, G.Laufer, F.J.Neumann, D.J.Richter, P.Schauerte, M.Sousa Uva, G.G.Stefanini, D.P.Taggart, L.Torracca, M.Valgimigli, W.Wijns, A.Witkowski 2014 ESC/EACTS Guidelines on myocardial revascularization:The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular \Interventions (EAPCI). Eur Heart J 2014;35:2541–2619.